| Name |
Related Structures |
Hours |
Description |
| Phase 1 - Independent Learning Results |
| Related Results |
| Introduction to Leadership Concepts | Class of 2023, Phase 1, 5730 - Physician Competencies I, Leadership 1 | 3 | |
| Normal Laboratory Values and Their Interpretations | Class of 2023, Phase 1, 5710 - The Healthy Person, 1. Introduction and Foundations | 1 | |
| Project Management for Physicians | Class of 2023, Phase 1, 5730 - Physician Competencies I, Leadership 1 | 3 | |
| Activation, Function, Interaction of T and B Lymphocytes | Class of 2023, Phase 1, 5710 - The Healthy Person, 2. Host Defence and Immune Mediated Disorders | 1 | |
| Antibody Diversification | Class of 2023, Phase 1, 5710 - The Healthy Person, 2. Host Defence and Immune Mediated Disorders | 1 | |
| Hypersensitivity Types 2 and 3 | Class of 2023, Phase 1, 5710 - The Healthy Person, 2. Host Defence and Immune Mediated Disorders | 1.5 | Materials provided in D2L site. |
| Special Populations | Class of 2023, Phase 1, 5740 - Community Engagement I, Concepts of Health & It’s Determinants | 2 | Aim: Health equity is defined as each person in society having an equal opportunity for health. With variations in the determinants of health, different populations have different risks and different health needs, and thus different access to the benefits of society. Physicians must be aware of the needs of special populations to ensure their practices effectively address specific risks and needs through appropriate services. This session will define special populations and identify determinants and practice issues related to these populations. |
| Chronic and Granulomatous Inflammation | Class of 2023, Phase 1, 5710 - The Healthy Person, 2. Host Defence and Immune Mediated Disorders | 1 | |
| Adverse Drug Reactions; Pharmacology | Class of 2023, Phase 1, 5710 - The Healthy Person, 2. Host Defence and Immune Mediated Disorders | 2 | |
| Name |
Related Structures |
Hours |
Description |
|